Photo Rounds

A progressive scalp lesion

Author and Disclosure Information

 

References

Finally, the patient sees some improvement

We discussed the risks and benefits of the various treatments, and our patient elected to start hydroxychloroquine (Plaquenil), 200 to 400 mg/day orally (not to exceed 6.5 mg/kg per day). We referred her for a baseline ophthalmological exam and stressed that she needed a repeat exam every 6 to 12 months while she remained on the hydroxychloroquine. We also referred her to a rheumatologist.

After 4 months of treatment, she showed some improvement (FIGURE 2), with no side effects from the medication. The patient was subsequently lost to follow-up.

FIGURE 2
A visible improvement


After 4 months of treatment with hydroxychloroquine, the patient’s scalp lesions improved and there was evidence of hair growth.

CORRESPONDENCE: Ahunna Ahiarah, MD, UB Family Medicine, 1315 Jefferson Avenue, Buffalo, NY 14208; aahiarah@buffalo.edu

Pages

The Journal of Family Practice ©2010 Dowden Health Media

Recommended Reading

Ustekinumab Bests Etanercept in Psoriasis Study
MDedge Family Medicine
ABCDEF Rule Guides Melanychia Diagnosis
MDedge Family Medicine
Guide to Coping With Medical Debt
MDedge Family Medicine
Melanoma Incidence Expected to Rise This Year
MDedge Family Medicine
Vigilance Key to Avoid Missing Melanomas
MDedge Family Medicine
Avoiding Acitretin in Fertile Women a Must
MDedge Family Medicine
NSAIDs Show No Effect on SCC Risk
MDedge Family Medicine
Multiple Melanomas a Real Phenomenon
MDedge Family Medicine
MRSA Warrants Culturing All Skin Infections
MDedge Family Medicine
Next-Generation Imiquimod Deemed More Convenient
MDedge Family Medicine